[
  {
    "ts": null,
    "headline": "Strategic Partnerships Power Tempus AI's Healthcare Expansion",
    "summary": "TEM deepens collaborations in oncology and neuroscience using its Lens and Next platforms to accelerate precision medicine.",
    "url": "https://finnhub.io/api/news?id=e9a1060a2adcc682fab9b12dc838b9a3f29f2255923019b8ae899fa3d08e5f63",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755610380,
      "headline": "Strategic Partnerships Power Tempus AI's Healthcare Expansion",
      "id": 136430132,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "TEM deepens collaborations in oncology and neuroscience using its Lens and Next platforms to accelerate precision medicine.",
      "url": "https://finnhub.io/api/news?id=e9a1060a2adcc682fab9b12dc838b9a3f29f2255923019b8ae899fa3d08e5f63"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Completes Acquisition of Capstan Therapeutics",
    "summary": "AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Capstan Therapeutics. With the completion of the acquisition, Capstan is now a part of AbbVie.",
    "url": "https://finnhub.io/api/news?id=baa7205ae4f2b25e797635b9c3c0624018edd68aeaa5a2ea93871f356ef608bc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755608100,
      "headline": "AbbVie Completes Acquisition of Capstan Therapeutics",
      "id": 136430133,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Capstan Therapeutics. With the completion of the acquisition, Capstan is now a part of AbbVie.",
      "url": "https://finnhub.io/api/news?id=baa7205ae4f2b25e797635b9c3c0624018edd68aeaa5a2ea93871f356ef608bc"
    }
  },
  {
    "ts": null,
    "headline": "SkinMedica® Unveils Its Newest Hydration Hero",
    "summary": "Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today the newest addition to the SkinMedica® HA5® Hydra Collagen portfolio. Featuring the brand's proprietary HA5® Hydra Collagen Complex – a blend of five forms of hyaluronic acid and vegan hydra collagen – the HA5® Hydra Collagen Hydrating Foaming Cleanser delivers instant hydration while providing a thorough cleanse, leaving skin feeling clean, calm, and cloud-soft.",
    "url": "https://finnhub.io/api/news?id=7b00fa6650ab9f7badd5072b0a492f2d772700d4245cef94e2de67f47172b1e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755604800,
      "headline": "SkinMedica® Unveils Its Newest Hydration Hero",
      "id": 136430134,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today the newest addition to the SkinMedica® HA5® Hydra Collagen portfolio. Featuring the brand's proprietary HA5® Hydra Collagen Complex – a blend of five forms of hyaluronic acid and vegan hydra collagen – the HA5® Hydra Collagen Hydrating Foaming Cleanser delivers instant hydration while providing a thorough cleanse, leaving skin feeling clean, calm, and cloud-soft.",
      "url": "https://finnhub.io/api/news?id=7b00fa6650ab9f7badd5072b0a492f2d772700d4245cef94e2de67f47172b1e4"
    }
  },
  {
    "ts": null,
    "headline": "Inside XBI: What The SPDR S&P Biotech ETF Offers Investors",
    "summary": "Discover the SPDR S&P Biotech ETF (XBI), an equal-weighted fund offering diversified exposure to U.S.",
    "url": "https://finnhub.io/api/news?id=cc606c638667f35ffa0f8b62417f3e85c0aec2b5d0bda61e63fb0c4a426fb5a3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755604467,
      "headline": "Inside XBI: What The SPDR S&P Biotech ETF Offers Investors",
      "id": 136424271,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1386962515/image_1386962515.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Discover the SPDR S&P Biotech ETF (XBI), an equal-weighted fund offering diversified exposure to U.S.",
      "url": "https://finnhub.io/api/news?id=cc606c638667f35ffa0f8b62417f3e85c0aec2b5d0bda61e63fb0c4a426fb5a3"
    }
  }
]